CDKN2A and oropharynx cancer: Strikingly, both studies only used p16-IHC to define HPV-related disease as an inclusion criterion, which is in line with current recommendations on HPV testing in oropharyngeal cancer patients according to guidelines of ESMO/ESTRO/EHNS [30] as well as College of American Pathologists [33].